Fig. 3: MMR after a minimum follow-up of 24 months.
a MMR according to study population and crossover. b Cumulative incidence of MMR accounting for competing risk. CI confidence interval, ITT intent-to-treat, MMR major molecular response.
Fig. 3: MMR after a minimum follow-up of 24 months. | Leukemia
